Growblox Sciences Look for Cannabis Patent for IBD Treatment

Growblox Life Sciences is seeking a patent for their marijuana-based products used to treat inflammatory diseases including Crohn’s disease and ulcerative colitis. Read about 10 potential risk factors for inflammatory bowel disease.  The Las Vegas-based company’s cannabinoid-containing complex mixtures (CCCM) work by disrupting the immune system’s pathway signals which contribute to IBD and other inflammatory diseases. The parent company,

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *